Get started
Author

Mahmood Aldapt

Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in TP53-mutated myelodysplastic syndromes
2026 · Mahmood Aldapt, Yu-Hung Wang, et al. · Haematologica · 1
PDF
Clinicopathologic Characteristics of Somatic TP53 Mutations in Philadelphia Chromosome–Negative Myeloproliferative Neoplasms: A Systematic Review
2026 · Mahmood Aldapt, Rasha Kaddoura, et al. · eJHaem
PDF
TCL-302: The Role of Frontline Hematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma-Not Otherwise Specified
2026 · Firas Baidoun, Mahmood Aldapt, et al. · Clinical Lymphoma Myeloma & Leukemia
MPN-129: Efficacy and Safety of Ropeginterferon in Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis
2026 · Aadhila Abbas Manthiri, Leen Haj Saleh, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-544: Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
2026 · Abdulrahman F Al-Mashdali, Mujahid O Abdelraof, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MPN-129: Efficacy and Safety of Ropeginterferon in Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis
2026 · Aadhila Abbas Manthiri, Leen Haj Saleh, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: TCL-302: The Role of Frontline Hematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma-Not Otherwise Specified
2026 · Firas Baidoun, Mahmood Aldapt, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-292: Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population
2026 · Mahmood Aldapt, Talha Badar, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-292: Weekly Hypomethylating Agent and Venetoclax Combination Therapy in Myeloid Neoplasms: A Real-World Single-Center Experience in an Older, High-Comorbidity Population
2026 · Mahmood Aldapt, Talha Badar, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-544: Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
2026 · Abdulrahman F Al-Mashdali, Mujahid O Abdelraof, et al. · Clinical Lymphoma Myeloma & Leukemia
Supplementary Material for: Weekly Metronomic Venetoclax and Decitabine/Cedazuridine in Acute Myeloid Leukemia Patient Declining Blood Transfusion
2026 · figshare admin karger, Aldapt M.B., et al. · Figshare
Weekly Metronomic Venetoclax and Decitabine/Cedazuridine in Acute Myeloid Leukemia Patient Declining Blood Transfusion
2026 · Mahmood Aldapt, Talha Badar, et al. · Case Reports in Oncology
PDF
Escape to learn: A team-based gamified educational experience for hematology/oncology fellows.
2026 · Emily Wolf, Reema Tawfiq, et al. · Journal of Clinical Oncology
Clinicopathologic characteristics of somatic TP53 mutations in Philadelphia chromosome–negative myeloproliferative neoplasms: A systematic review and pooled analysis.
2026 · Mahmood Aldapt, Rasha Kaddoura, et al. · Journal of Clinical Oncology
PDF
Works count: 14
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type